BALAXI PHARMACEUTICALS LIMITED — Important, 30-05-2025: General Updates

Balaxi Pharmaceuticals has announced a board meeting on August 25, 2025, approving the financial results for the quarter and half-year. It reported a standalone net profit of Rs. 3.6 Cr and a consolidated net profit of Rs. 1,093.39 Cr for the year. The company completed construction of its first formulation plant in Jadcherla, Hyderabad, with validation underway and manufacturing license pending. Strong operational cash flows are fueling ongoing expansions. Internal and secretarial auditors have been appointed for a five-year term, pending shareholder approval.